Back to Search
Start Over
Pharmacoeconomic aspects of the use of bronchodilators in the management of COPD: real clinical practice
- Source :
- Медицинский совет, Vol 0, Iss 21, Pp 96-104 (2019)
- Publication Year :
- 2019
- Publisher :
- Remedium Group LLC, 2019.
-
Abstract
- Today, chronic obstructive pulmonary disease is the fourth global cause of deaths worldwide. A number of studies showed that 11 to 16 million people might suffer from the chronic obstructive pulmonary disease in Russia. The prevalence and high mortality of this disease lead to a significant socio-economic burden. A pharmacoeconomic comparison of two alternative drug technologies in the studied groups grants the reasonable opportunity to transfer patients to the domestic analogues, confirming that efficiency unit costs for using Tiotropium-native and Ipraterol-native are lower than the same costs for using the foreign drugs Spiriva and Berodual.
Details
- Language :
- Russian
- ISSN :
- 2079701X and 26585790
- Issue :
- 21
- Database :
- Directory of Open Access Journals
- Journal :
- Медицинский совет
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.801fc0dd1f8d4d5ab76aace394ba1fdb
- Document Type :
- article
- Full Text :
- https://doi.org/10.21518/2079-701X-2018-21-96-104